Breaking News Instant updates and real-time market news.

ALDR

Alder Biopharmaceuticals

$14.29

-0.07 (-0.49%)

08:31
11/06/18
11/06
08:31
11/06/18
08:31

Alder Biopharmaceuticals resumed with an Outperform at Wells Fargo

Wells Fargo analyst Jim Birchenough resumed coverage of Alder Biopharmaceuticals with an Outperform rating and $36 price target following review of Q3 operating results and ahead of expected BLA filing for novel CGRP antibody eptinezumab for migraine prevention. While commercial execution will be key, the analyst believes that differentiated delivery and reimbursement as well as key product attributes of greater speed and depth of response should support a significant opportunity and potentially attract large pharma/biotech interest.

  • 06

    Nov

  • 12

    Nov

  • 27

    Nov

ALDR Alder Biopharmaceuticals
$14.29

-0.07 (-0.49%)

10/12/18
10/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Molina Healthcare (MOH) downgraded to Hold from Buy at Jefferies with analyst David Windley citing valuation. 2. Genesee & Wyoming (GWR) downgraded to Neutral from Overweight at JPMorgan with analyst Brian Ossenbeck saying the stock is up 20% since the Q4 of 2017 earnings as management completed divesting the majority of the failed European acquisition and opportunistically repurchased 3% of the shares outstanding. 3. Oneok (OKE) downgraded to Equal Weight from Overweight at Barclays. 4. Alder Biopharmaceuticals (ALDR) downgraded to Neutral from Buy at Mizuho with analyst Difei Yang saying she sees limited catalysts between an anticipated biologics license application submission in Q1 of 2019 and commercial launch expected in 2020. 5. Veon (VEON) downgraded to Neutral from Buy at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/18
MZHO
10/12/18
DOWNGRADE
Target $15
MZHO
Neutral
Alder Biopharmaceuticals downgraded to Neutral from Buy at Mizuho
Mizuho analyst Difei Yang downgraded Alder Biopharmaceuticals to Neutral and lowered her price target for the shares to $15 from $29. The analyst sees limited catalysts between an anticipated biologics license application submission in Q1 of 2019 and commercial launch expected in 2020. Investors could remain on the sidelines and away from higher risk names given the current higher volatility in the market, Yang tells investors in a research note.
09/10/18
09/10/18
INITIATION
Target $19

Underweight
Morgan Stanley starts Alder at Underweight given crowded migraine market
As previously reported, Morgan Stanley analyst Jeffrey Hung started Alder Biopharmaceuticals with an Underweight rating, noting that the company's migraine drug will be the fourth to market of the same class. Alder's drug has a fast onset, but he views efficacy across these drugs as largely similar, Hung tells investors. The consensus estimate of $750M for Alder's drug by 2025 needs to come down, according to the analyst, who set a $19 price target on the stock.
09/10/18
MSCO
09/10/18
INITIATION
MSCO
Underweight
Alder Biopharmaceuticals initiated with an Underweight at Morgan Stanley

TODAY'S FREE FLY STORIES

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

09:36
02/22/19
02/22
09:36
02/22/19
09:36
Hot Stocks
Magellan Health says will consider Starboard Value director nominees »

Magellan Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

EHTH

eHealth

$65.58

-0.28 (-0.43%)

09:36
02/22/19
02/22
09:36
02/22/19
09:36
Recommendations
eHealth analyst commentary  »

eHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NXTM

NxStage Medical

$30.00

0.005 (0.02%)

, FMS

Fresenius Medical

$39.83

-0.06 (-0.15%)

09:33
02/22/19
02/22
09:33
02/22/19
09:33
Hot Stocks
NxStage Medical takeover by Fresenius Medical effective Feb. 21 »

NxStage Medical (NXTM)…

NXTM

NxStage Medical

$30.00

0.005 (0.02%)

FMS

Fresenius Medical

$39.83

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

09:33
02/22/19
02/22
09:33
02/22/19
09:33
Downgrade
Kraft Heinz rating change  »

Kraft Heinz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.76

0.12 (0.68%)

09:31
02/22/19
02/22
09:31
02/22/19
09:31
Recommendations
Wendy's analyst commentary  »

Wendy's shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

ROKU

Roku

$51.47

-2.16 (-4.03%)

09:31
02/22/19
02/22
09:31
02/22/19
09:31
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOS

Mosaic

$33.17

-0.29 (-0.87%)

09:30
02/22/19
02/22
09:30
02/22/19
09:30
Downgrade
Mosaic rating change  »

Mosaic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Mar

  • 28

    May

BJRI

BJ's Restaurants

$51.97

0.75 (1.46%)

09:28
02/22/19
02/22
09:28
02/22/19
09:28
Recommendations
BJ's Restaurants analyst commentary  »

BJ's Restaurants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$150.18

0.07 (0.05%)

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

VZ

Verizon

$56.14

0.35 (0.63%)

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Recommendations
Verizon analyst commentary  »

5G financial impact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Conference/Events
Global Blood Therapeutics participates in a conference call with JPMorgan »

Biotech Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Conference/Events
UBS services analyst to hold an analyst/industry conference call »

Services Analyst Geiger,…

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

EXPGY

Experian

$0.00

(0.00%)

, EFX

Equifax

$110.51

2.61 (2.42%)

09:24
02/22/19
02/22
09:24
02/22/19
09:24
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

EXPGY

Experian

$0.00

(0.00%)

EFX

Equifax

$110.51

2.61 (2.42%)

TRU

TransUnion

$63.16

0.2 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

QTS

QTS Realty Trust

$43.52

-0.78 (-1.76%)

09:21
02/22/19
02/22
09:21
02/22/19
09:21
Hot Stocks
QTS Realty Trust raises quarterly dividend to 44c from 41c per share »

Payable on April 4 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 11

    Mar

  • 09

    May

DDAIF

Daimler AG

$0.00

(0.00%)

, PCAR

Paccar

$69.18

0.17 (0.25%)

09:20
02/22/19
02/22
09:20
02/22/19
09:20
Hot Stocks
EU commercial vehicle registrations up 6.2% in January »

In January, the EU market…

DDAIF

Daimler AG

$0.00

(0.00%)

PCAR

Paccar

$69.18

0.17 (0.25%)

CNHI

CNH Industrial

$10.67

0.04 (0.38%)

NAV

Navistar

$37.95

0.3697 (0.98%)

CMI

Cummins

$154.05

-0.18 (-0.12%)

ALSN

Allison Transmission

$49.66

0.07 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ANIK

Anika Therapeutics

$40.45

0.45 (1.13%)

09:18
02/22/19
02/22
09:18
02/22/19
09:18
Recommendations
Anika Therapeutics analyst commentary  »

Anika Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDCE

PDC Energy

$38.74

-0.51 (-1.30%)

09:18
02/22/19
02/22
09:18
02/22/19
09:18
Hot Stocks
PDC Energy issues statement on Kimmeridge 13D filing »

PDC Energy issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SPX

S&P 500

$0.00

(0.00%)

09:18
02/22/19
02/22
09:18
02/22/19
09:18
Options
Overnight activity included 196 trades in SPX »

196 trades were executed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLED

Universal Display

$118.31

-0.57 (-0.48%)

09:17
02/22/19
02/22
09:17
02/22/19
09:17
Recommendations
Universal Display analyst commentary  »

Universal Display price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$138.85

-1.44 (-1.03%)

, XRX

Xerox

$31.34

0.47 (1.52%)

09:16
02/22/19
02/22
09:16
02/22/19
09:16
Periodicals
EU may retaliate against Caterpillar, Xerox 'if Trump hits cars,' Bloomberg says »

According to a report out…

CAT

Caterpillar

$138.85

-1.44 (-1.03%)

XRX

Xerox

$31.34

0.47 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$155.31

2.75 (1.80%)

09:15
02/22/19
02/22
09:15
02/22/19
09:15
Upgrade
Pool Corp. rating change  »

Pool Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

XLNX

Xilinx

$119.20

-0.83 (-0.69%)

09:14
02/22/19
02/22
09:14
02/22/19
09:14
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

FSLR

First Solar

$51.91

0.23 (0.45%)

09:13
02/22/19
02/22
09:13
02/22/19
09:13
Recommendations
First Solar analyst commentary  »

First Solar remains top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$21.70

3.44 (18.84%)

09:12
02/22/19
02/22
09:12
02/22/19
09:12
Recommendations
Delphi Technologies analyst commentary  »

Delphi Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.